GEN Exclusives

More »

GEN News Highlights

More »
Sep 7, 2007

Diagnostic Test for Melanoma Goal of NYU Medical Center and Rosetta Genomics Partnership

  • Rosetta Genomics will be working with NYU Medical Center to develop a diagnostic test for melanoma. The partners will focus on identifing miRNAs that can be used as prognostic indicators for the overall survival of melanoma patients and the risk that the disease will metastasize to distant sites.

    “We believe that through our work with microRNAs, which have been shown to hold tremendous potential as biomarkers, we will be able to better understand both the origins and the development of the disease,” comments Eva Hernando of the department of pathology at the NYU School of Medicine. “NYU’s extensive experience with melanoma combined with Rosetta Genomics knowledge in microRNAs offers an exciting research opportunity.”



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?